44th Annual San Antonio Breast Cancer Symposium (SABCS)

SABCS is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.

SABCS welcomes attendance by informed patient advocates representing recognized patient advocacy, education & survivor support organizations.

43rd Annual San Antonio Breast Cancer Symposium (SABCS)

SABCS is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.

SABCS welcomes attendance by informed patient advocates representing recognized patient advocacy, education & survivor support organizations.

2nd International Invasive Lobular Breast Cancer Symposium

The University of Pittsburgh Cancer Institute (UPCI) will host the second Invasive Lobular Carcinoma (ILC) International Symposium. Clinical experts will explore ILC, the second most common type of breast cancer and the eighth most common cancer in women. The goal is to begin the process of leading research that will ultimately result in improved outcomes for patients with this disease.

ILC is often difficult to diagnose since it typically does not cause a firm or distinct breast lump. Clinical and laboratory studies of breast cancer have focused almost exclusively on the more common invasive ductal cancers (IDC). Prior to the first ILC symposium held in 2016, there has never been a focused meeting to discuss basic, translational and clinical research on ILC, which affects nearly 30,000 women each year.

The target audience for this symposium is researchers interested in lobular cancer, as well as medical, surgical, and radiation oncologists interested in the treatment of patients with invasive lobular carcinoma in situ (LCIS) or ILC. Patient advocate breakout sessions and networking opportunities will  be included in the program. Patient advocates for lobular cancer and other healthcare professionals are encouraged to attend.

42 Annual San Antonio Breast Cancer Symposium (SABCS)

SABCS is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.

SABCS welcomes attendance by informed patient advocates representing recognized patient advocacy, education & survivor support organizations.

5th ESO-ESMO Advanced Breast Cancer (ABC5) International Consensus Conference

The International Consensus Conference for Advanced Breast Cancer (ABC) has established itself as a major international breast cancer conference. Its primary aim is the development of international consensus guidelines for the management of ABC patients. These guidelines are based on the most up-to-date evidence and can be used to guide treatment decision making in many different health care settings globally, with the necessary adaptations due to different access to care.

We believe that health professionals working closely together with patient advocates and with the strong support of media can raise awareness about the needs and challenges faced by this traditionally underserved and forgotten group of patients. ABC also aims to identify research priorities based on the most important areas of unmet need, analyse and discuss available data to provide the most accurate management recommendations, as well as influence policy makers and funding bodies and ultimately improve standards of care, survival and quality of life. Research and education, with accurate usage of available knowledge, throughout the world, are key to achieve these goals.

2nd Annual Minneapolis Metsquerade

The Metsquerade is a fundraising event to benefit Metavivor. METAvivor is dedicated to the specific fight of women and men living with stage IV metastatic breast cancer. At the time of METAvivor’s founding, no organization was dedicated to funding research for the disease and no patient groups were speaking out about the dearth of stage 4 cancer research.  While more and more people have taken up the cry for more stage 4 research, METAvivor remains the sole US organization dedicated to awarding annual metastatic breast cancer research grants.

The Southwest Florida Metsquerade is one of many Metsquerades to sweep the nation and is dedicated to funding research for metastatic breast cancer (MBC). This is the only event of its kind where 100% of donations go to metastatic breast cancer research.

Living Beyond Breast Cancer (LBBC)’s Annual Conference

The 2019 Living Beyond Breast Cancer Conference brings together leading medical and wellness professionals, people affected by breast cancer and caregivers to learn, connect and share. Whether you are recently diagnosed with breast cancer, are in treatment or years beyond it you may have questions, concerns or are just looking to connect to other people who have been impacted by breast cancer. This is the place for you!

Highlights of the conference weekend include:

  • Presentations on the latest research and treatment options
  • Time to socialize, connect and share
  • Tailored information for your sub-type and stage
  • Exhibitors with products and services just for you
  • and much more!

Theresa’s Research Foundation’s MBC Conference

The mission of this conference is to bring together a diverse audience to create a collaborative research environment with a long term goal of developing curative approaches for metastatic breast cancer patients.

Background:

The Metastatic Breast Cancer Conference was established in 2014 as an annual medical conference for metastatic breast cancer by Theresa’s Research Foundation with leadership from Dr. Matthew Ellis and Dr. Danny Welch. The specific focus on metastatic disease is based on a major unmet clinical need (incurability); thereby distinguishing this conference from other breast cancer-centered conferences. The first conference was hosted at the University of Kansas Cancer Center. In 2015, 2016 and 2017 the MBCC was hosted at Baylor College of Medicine. The 2018 Conference was held at Johns Hopkins University School of Medicine. Additional leadership is provided by Dr. Xiang Zhang and the conference planning committee.

Best of ASCO Meetings- Baltimore, MD

The Best of American Society of Clinical Oncology (ASCO) Meetings condense the most cutting-edge science and education from the world’s premier oncology event, the ASCO Annual Meeting, into a two-day program of scientific findings with practice-changing discussions. The abstracts chosen for presentation and discussion reflect the foremost research and strategies in oncology that will directly impact patient care.

Up ↑